Business / Finance

RSS

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

BBI Solutions, a world leader in immunoassay development and contract manufacturing, recently launched its unique range of Recombinant Fab Monoclonal Antibodies at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo, on July 28-August 31, 2013, in Houston, Texas.

19 Nov 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in the field of products and services for human in vitro diagnostics and pharmaceutical research.

18 Nov 2013

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

Eisai announces today that Halaven (eribulin) will be marketed in selected countries within the Middle East region through a new partnership between Eisai EMEA (Europe, the Middle East, Africa, Russia and Oceania) and NewBridge Pharmaceuticals.

18 Nov 2013

M1T invests $3.4 million in Cloud Medical

M1T, an American business active in the Health Care industry, has made an investment of $3.4 Million in Cloud Medical, completing the company series A round. Cloud is a Healthcare IT company focused on deploying hardware and software systems that will minimize inefficiencies related to compliance and auditing, giving providers more control over medical procedures, processes and records.

16 Nov 2013

Kindred Healthcare to acquire Synergy Home Care

Synergy Home Care, a premier home health care provider that operates through 17 locations in Louisiana, has signed a definitive agreement to be acquired by Kindred Healthcare, Inc. The transaction is expected to close in the fourth quarter of 2013, pending regulatory approvals and other customary conditions.

16 Nov 2013

ZOLL Medical announces establishment of ZOLL Foundation

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today the establishment of the ZOLL Foundation, an independent entity organized for scientific and educational purposes.

16 Nov 2013

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

GoInformatics and TeselaGen have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace.

16 Nov 2013

CHEST, Chinese Thoracic Society partner to unify specialties of pulmonary and critical care in China

The American College of Chest Physicians and the Chinese Thoracic Society have formally agreed to collaborate to develop and launch fellowship programs in pulmonary and critical care medicine in China.

15 Nov 2013

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that its wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co., Ltd., has entered into a supply arrangement with Pharmacyclics, Inc.

15 Nov 2013

Designation of ISIS-GSK4Rx as a development candidate triggers milestone payment to Isis

Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.

15 Nov 2013

TPI’s revenue decreases 8.1% to $14.8 million in first quarter fiscal year 2014

Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter fiscal year 2014.

15 Nov 2013

AUXILIO reports financial results for third quarter 2013

AUXILIO, Inc., the nation's pioneer and leading Managed Print Services (MPS) company for health care, today reported financial results for its quarter ended September 30, 2013.

15 Nov 2013

UHS total revenues increase 2.4% to $104.3 million in Q3 2013

Universal Hospital Services, Inc., a leading provider of medical equipment management and service solutions, today announced financial results for the quarter ended September 30, 2013.

15 Nov 2013

InnerWorkings enters into new multi-year procurement partnership with Easter Seals

InnerWorkings, Inc., a leading global marketing supply chain company, and Easter Seals, the leading nonprofit provider of services for individuals with autism, developmental disabilities, physical and mental disabilities and other special needs, today announced a new multi-year fundraising-focused procurement partnership. Under the agreement, InnerWorkings will manage the printing and logistics of Easter Seals' fundraising materials.

15 Nov 2013

AdCare Health Systems third quarter 2013 revenues up 5%

AdCare Health Systems, Inc., a leading long-term care provider, reported results for the third quarter and nine months ended September 30, 2013.

15 Nov 2013

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

Global Genomics Group and Metabolon today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases.

15 Nov 2013

Biostar Pharmaceuticals reports revenue of $15.01M for third quarter 2013

Biostar Pharmaceuticals, Inc., a PRC based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results of the third quarter ended September 30, 2013.

14 Nov 2013

Sorrento Therapeutics to acquire San Diego-based Concortis Biosystems

Sorrento Therapeutics, Inc. announced today the entry into a definitive agreement to acquire San Diego-based Concortis Biosystems, Corp. in a deal that provides Sorrento with a comprehensive technology platform for generation of antibody drug conjugates (ADC). Under the terms of the agreement dated November 11, 2013, subject to satisfaction of certain closing conditions, upon closing, Sorrento will issue an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders.

14 Nov 2013

Nutranomics to distribute Nutriband transdermal delivery system in North America

Nutranomics, Inc. is pleased to announce that the Company has acquired the exclusive North American sales and distribution rights to the Nutriband delivery system, an innovative and commercialized health supplement transdermal patch system currently available in Europe.

14 Nov 2013

Business / Finance

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

New range of recombinant Fab monoclonal antibodies launched by BBI Solutions at Medica 2013

Argos Soditic-managed funds announce acquisition of Cisbio Bioassays

Eisai partners with NewBridge Pharmaceuticals to market Halaven drug in Middle East

M1T invests $3.4 million in Cloud Medical

Kindred Healthcare to acquire Synergy Home Care

ZOLL Medical announces establishment of ZOLL Foundation

GoInformatics, TeselaGen form strategic partnership to offer cutting-edge biodesign automation tools

CHEST, Chinese Thoracic Society partner to unify specialties of pulmonary and critical care in China

WuXi PharmaTech subsidiary enters into supply arrangement with Pharmacyclics

Designation of ISIS-GSK4Rx as a development candidate triggers milestone payment to Isis

TPI’s revenue decreases 8.1% to $14.8 million in first quarter fiscal year 2014

AUXILIO reports financial results for third quarter 2013

UHS total revenues increase 2.4% to $104.3 million in Q3 2013

InnerWorkings enters into new multi-year procurement partnership with Easter Seals

AdCare Health Systems third quarter 2013 revenues up 5%

Global Genomics Group, Metabolon partner to discover novel targets for cardiovascular diseases

Biostar Pharmaceuticals reports revenue of $15.01M for third quarter 2013

Sorrento Therapeutics to acquire San Diego-based Concortis Biosystems

Nutranomics to distribute Nutriband transdermal delivery system in North America

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News